HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

3rd Edition of Global Conference on Gynecology & Women's Health

October 27-29, 2025 | Orlando, Florida, USA

Gynec 2025

High-risk HPV DNA testing in self-collected vaginal samples compared to cytological screening for cervical cancer detection: A brazilian multicenter study

Speaker at Gynecology & Women's Health - Janaina Cristiana de Oliveira Crispim
Federal University of Rio Grande do Norte, Natal, RN, Brazil
Title : High-risk HPV DNA testing in self-collected vaginal samples compared to cytological screening for cervical cancer detection: A brazilian multicenter study

Abstract:

Introduction: Cervical cancer remains a significant public health issue, particularly in low- and middle-income countries, where screening coverage is often limited. Alternative strategies such as self-sampling combined with high-risk HPV testing may improve detection rates and increase participation in screening programs. This study aims to compare self-sampling combined with high-risk HPV testing (hrHPV+) versus the Papanicolaou test (Pap) as two modalities for cervical cancer screening.

Methods: This was a cross-sectional study conducted at two primary healthcare units in Parnamirim, RN, Brazil. The study was approved by the Research Ethics Committee (CAAE: 83854924.9.2006.0253). Women aged 25 to 64 who had not undergone a Pap test in the past four years or more were included. Participants outside the defined age range, with a history of hysterectomy, or who had recently undergone a Pap test were excluded. Participants were stratified into two groups: (1) the Self-Sampling Group, which received a “Coari” self-collection kit, and (2) the Pap Group, which underwent conventional cytological sampling. Self-collected samples were analysed using the COBAS HPV kit, which detects HPV types 16, 18, and 12 other high-risk types. Women with abnormal results (Pap ≥ ASC-US or hrHPV+) were referred for colposcopy and biopsy.

Results: A total of 160 self-sampling/HPV tests were performed, yielding 18 positive results (HPV16 = 9; HPV18 = 1; other high-risk types = 14). Women who tested positive for high-risk HPV were referred for colposcopy and biopsy. In the Pap test group, 121 samples were collected, with 11 abnormal results: ASC-US (n = 8), HSIL (n = 1), LSIL (n = 1), and AGC-NOS (n = 1).

Conclusion: Self-sampling combined with hrHPV+ testing demonstrated higher sensitivity for detecting positive cases and showed good acceptability among women, supporting its potential as an effective screening strategy alongside the conventional model.

Biography:

Dr. Janaina Cristiana de Oliveira Crispim is Associate Professor in the Department of Clinical and Toxicological Analysis at the Federal University of Rio Grande do Norte (UFRN). PhD in Basic and Applied Immunology and Postdoctoral Fellow at Ribeirao Preto Medical School, University of Sao Paulo. She coordinates the Postgraduate Program in Science Applied to Women’s Health and the Graduate Program in Oncological Gynecologic Cytology at UFRN. She leads the CNPq research group “Women's and Maternal-Child Health Care.” Her expertise lies in Immunology and Cytology, with a focus on women’s health. She also coordinates the Laboratory of Oncological Gynecologic Cytology and Immunology Research at UFRN.

Watsapp